Your browser doesn't support javascript.
loading
Tissue-Biased Expansion of DNMT3A-Mutant Clones in a Mosaic Individual Is Associated with Conserved Epigenetic Erosion.
Tovy, Ayala; Reyes, Jaime M; Gundry, Michael C; Brunetti, Lorenzo; Lee-Six, Henry; Petljak, Mia; Park, Hyun Jung; Guzman, Anna G; Rosas, Carina; Jeffries, Aaron R; Baple, Emma; Mill, Jonathan; Crosby, Andrew H; Sency, Valerie; Xin, Baozhong; Machado, Heather E; Castillo, Danielle; Weitzel, Jeffrey N; Li, Wei; Stratton, Michael R; Campbell, Peter J; Wang, Heng; Sanders, Mathijs A; Goodell, Margaret A.
Affiliation
  • Tovy A; Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, TX, USA; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA.
  • Reyes JM; Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, TX, USA; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA.
  • Gundry MC; Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, TX, USA; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
  • Brunetti L; Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, TX, USA.
  • Lee-Six H; Cancer, Ageing, and Somatic Mutation, Wellcome Sanger Institute, Hinxton, UK.
  • Petljak M; Cancer, Ageing, and Somatic Mutation, Wellcome Sanger Institute, Hinxton, UK.
  • Park HJ; Division of Biostatistics, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA.
  • Guzman AG; Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, TX, USA; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA.
  • Rosas C; Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, TX, USA; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA.
  • Jeffries AR; RILD Wellcome Wolfson Centre, University of Exeter, Royal Devon & Exeter NHS Foundation Trust, Exeter, UK.
  • Baple E; RILD Wellcome Wolfson Centre, University of Exeter, Royal Devon & Exeter NHS Foundation Trust, Exeter, UK.
  • Mill J; RILD Wellcome Wolfson Centre, University of Exeter, Royal Devon & Exeter NHS Foundation Trust, Exeter, UK.
  • Crosby AH; RILD Wellcome Wolfson Centre, University of Exeter, Royal Devon & Exeter NHS Foundation Trust, Exeter, UK.
  • Sency V; DDC Clinic Center for Special Needs Children, Middlefield, OH, USA; Department of Pediatrics, Rainbow Babies & Children's Hospital, Cleveland, OH, USA; Department of Molecular Cardiology, Cleveland Clinic, Cleveland, OH, USA.
  • Xin B; DDC Clinic Center for Special Needs Children, Middlefield, OH, USA; Department of Pediatrics, Rainbow Babies & Children's Hospital, Cleveland, OH, USA; Department of Molecular Cardiology, Cleveland Clinic, Cleveland, OH, USA.
  • Machado HE; Cancer, Ageing, and Somatic Mutation, Wellcome Sanger Institute, Hinxton, UK.
  • Castillo D; City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Weitzel JN; City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Li W; Division of Biostatistics, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA.
  • Stratton MR; Cancer, Ageing, and Somatic Mutation, Wellcome Sanger Institute, Hinxton, UK.
  • Campbell PJ; Cancer, Ageing, and Somatic Mutation, Wellcome Sanger Institute, Hinxton, UK.
  • Wang H; DDC Clinic Center for Special Needs Children, Middlefield, OH, USA; Department of Pediatrics, Rainbow Babies & Children's Hospital, Cleveland, OH, USA; Department of Molecular Cardiology, Cleveland Clinic, Cleveland, OH, USA.
  • Sanders MA; Cancer, Ageing, and Somatic Mutation, Wellcome Sanger Institute, Hinxton, UK; Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands. Electronic address: ms44@sanger.ac.uk.
  • Goodell MA; Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, TX, USA; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA. Electronic address: goodell
Cell Stem Cell ; 27(2): 326-335.e4, 2020 08 06.
Article in En | MEDLINE | ID: mdl-32673568
ABSTRACT
DNA methyltransferase 3A (DNMT3A) is the most commonly mutated gene in clonal hematopoiesis (CH). Somatic DNMT3A mutations arise in hematopoietic stem cells (HSCs) many years before malignancies develop, but difficulties in comparing their impact before malignancy with wild-type cells have limited the understanding of their contributions to transformation. To circumvent this limitation, we derived normal and DNMT3A mutant lymphoblastoid cell lines from a germline mosaic individual in whom these cells co-existed for nearly 6 decades. Mutant cells dominated the blood system, but not other tissues. Deep sequencing revealed similar mutational burdens and signatures in normal and mutant clones, while epigenetic profiling uncovered the focal erosion of DNA methylation at oncogenic regulatory regions in mutant clones. These regions overlapped with those sensitive to DNMT3A loss after DNMT3A ablation in HSCs and in leukemia samples. These results suggest that DNMT3A maintains a conserved DNA methylation pattern, the erosion of which provides a distinct competitive advantage to hematopoietic cells.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: DNA (Cytosine-5-)-Methyltransferases / Hematopoiesis Type of study: Risk_factors_studies Language: En Journal: Cell Stem Cell Year: 2020 Document type: Article Affiliation country: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: DNA (Cytosine-5-)-Methyltransferases / Hematopoiesis Type of study: Risk_factors_studies Language: En Journal: Cell Stem Cell Year: 2020 Document type: Article Affiliation country: Estados Unidos
...